Literature DB >> 9099230

PM-94128, a new isocoumarin antitumor agent produced by a marine bacterium.

L M Cañedo1, J L Fernández Puentes, J Pérez Baz, C Acebal, F de la Calle, D García Grávalos, T García de Quesada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9099230     DOI： 10.7164/antibiotics.50.175

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  11 in total

1.  In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics.

Authors:  I V Pinchuk; P Bressollier; B Verneuil; B Fenet; I B Sorokulova; F Mégraud; M C Urdaci
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

2.  (2R)-2-(1,3-Dioxoisoindolin-2-yl)-4-(methyl-sulfan-yl)butanoic acid.

Authors:  Abdul Rauf Raza; M Nawaz Tahir; Aisha Saddiqa; Muhammad Danish; M Saeed Iqbal
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-07-25

3.  3-(4-Methoxy-phen-yl)-1H-isochromen-1-one.

Authors:  T Maiyalagan; Venkatesha R Hathwar; P Manivel; N Burcu Arslan; F Nawaz Khan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-12-17

4.  3-(3-Fluoro-benz-yl)-1H-isochromen-1-one.

Authors:  Tariq Mahmood Babar; Ghulam Qadeer; Obaid-Ur-Rahman Abid; Nasim Hassan Rama; Ales Ruzicka
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-11-08

5.  Amicoumacin a inhibits translation by stabilizing mRNA interaction with the ribosome.

Authors:  Yury S Polikanov; Ilya A Osterman; Teresa Szal; Vadim N Tashlitsky; Marina V Serebryakova; Pavel Kusochek; David Bulkley; Irina A Malanicheva; Tatyana A Efimenko; Olga V Efremenkova; Andrey L Konevega; Karen J Shaw; Alexey A Bogdanov; Marina V Rodnina; Olga A Dontsova; Alexander S Mankin; Thomas A Steitz; Petr V Sergiev
Journal:  Mol Cell       Date:  2014-10-09       Impact factor: 17.970

6.  Five new amicoumacins isolated from a marine-derived bacterium Bacillus subtilis.

Authors:  Yongxin Li; Ying Xu; Lingli Liu; Zhuang Han; Pok Yui Lai; Xiangrong Guo; Xixiang Zhang; Wenhan Lin; Pei-Yuan Qian
Journal:  Mar Drugs       Date:  2012-02-03       Impact factor: 6.085

7.  Response of methicillin-resistant Staphylococcus aureus to amicoumacin A.

Authors:  Amrita Lama; Jan Pané-Farré; Tai Chon; Anna M Wiersma; Clarissa S Sit; John C Vederas; Michael Hecker; Michiko M Nakano
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

8.  Amicoumacin A induces cancer cell death by targeting the eukaryotic ribosome.

Authors:  Irina V Prokhorova; Kseniya A Akulich; Desislava S Makeeva; Ilya A Osterman; Dmitry A Skvortsov; Petr V Sergiev; Olga A Dontsova; Gulnara Yusupova; Marat M Yusupov; Sergey E Dmitriev
Journal:  Sci Rep       Date:  2016-06-14       Impact factor: 4.379

9.  Mechanism of the Potential Therapeutic Candidate Bacillus subtilis BSXE-1601 Against Shrimp Pathogenic Vibrios and Multifunctional Metabolites Biosynthetic Capability of the Strain as Predicted by Genome Analysis.

Authors:  Dongdong Wang; Jiahui Li; Guoliang Zhu; Kun Zhao; Wenwen Jiang; Haidong Li; Wenjun Wang; Vikash Kumar; Shuanglin Dong; Weiming Zhu; Xiangli Tian
Journal:  Front Microbiol       Date:  2020-10-26       Impact factor: 5.640

10.  Hetiamacin E and F, New Amicoumacin Antibiotics from Bacillus subtilis PJS Using MS/MS-Based Molecular Networking.

Authors:  Ting Wang; Qinpei Lu; Chenghang Sun; Dmitrii Lukianov; Ilya Andreevich Osterman; Petr Vladimirovich Sergiev; Olga Anatolievna Dontsova; Xinxin Hu; Xuefu You; Shaowei Liu; Gang Wu
Journal:  Molecules       Date:  2020-09-27       Impact factor: 4.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.